Ultra sensitive and quantitative method for non-invasive cancer detection.
–Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
–Naveris, Inc. to provide NavDx® blood test to Cancer Centers of Excellence
–Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
–HPV blood test shows promise for tracking head and neck cancer after treatment